{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:28:27Z","timestamp":1773152907183,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2007,10,18]]},"DOI":"10.1007\/s11010-007-9573-8","type":"journal-article","created":{"date-parts":[[2007,8,22]],"date-time":"2007-08-22T16:45:04Z","timestamp":1187801104000},"page":"221-230","source":"Crossref","is-referenced-by-count":4,"title":["Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice"],"prefix":"10.1007","volume":"306","author":[{"given":"S. Jeson","family":"Sangaralingham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Yat","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"9573_CR1","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/0003-4819-117-12-1016","volume":"117","author":"D Grady","year":"1992","unstructured":"Grady D, Rubin SM, Petitti DB et\u00a0al (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016\u20131037","journal-title":"Ann Intern Med"},{"key":"9573_CR2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.CIR.92.3.380","volume":"92","author":"JM Gardin","year":"1995","unstructured":"Gardin JM, Wagenknecht LE, Anton-Culver H et\u00a0al (1995) Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary artery risk development in young adults. Circulation 92:380\u2013387","journal-title":"Circulation"},{"key":"9573_CR3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00001573-199409000-00018","volume":"9","author":"ME Mendelsohn","year":"1994","unstructured":"Mendelsohn ME, Karas RH (1994) Estrogen and the blood vessel wall. Curr Opin Cardiol 9:619\u2013626","journal-title":"Curr Opin Cardiol"},{"key":"9573_CR4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archinte.1995.00430010063008","volume":"155","author":"WB Kannel","year":"1995","unstructured":"Kannel WB, Wilson PW (1995) Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 155:57\u201361","journal-title":"Arch Intern Med"},{"key":"9573_CR5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0008-6363(01)00526-0","volume":"53","author":"FA Babiker","year":"2002","unstructured":"Babiker FA, de Windt LJ, van Eickels M et\u00a0al (2002) Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc Res 53:709\u2013719","journal-title":"Cardiovasc Res"},{"key":"9573_CR6","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD et\u00a0al (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561\u20131566","journal-title":"N Engl J Med"},{"key":"9573_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(97)01179-4","volume":"416","author":"C Grohe","year":"1997","unstructured":"Grohe C, Kahlert S, Lobbert K et\u00a0al (1997) Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416:107\u2013112","journal-title":"FEBS Lett"},{"key":"9573_CR8","doi-asserted-by":"crossref","first-page":"134S","DOI":"10.1016\/j.amjhyper.2005.05.005","volume":"18","author":"BI Levy","year":"2005","unstructured":"Levy BI (2005) How to explain the differences between renin angiotensin system modulators. Am J Hypertens 18:134S\u2013141S","journal-title":"Am J Hypertens"},{"key":"9573_CR9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0008-6363(99)00145-5","volume":"43","author":"KC Wollert","year":"1999","unstructured":"Wollert KC, Drexler H (1999) The renin-angiotensin system and experimental heart failure. Cardiovasc Res 43:838\u2013849","journal-title":"Cardiovasc Res"},{"key":"9573_CR10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0008-6363(01)00479-5","volume":"53","author":"M Fischer","year":"2002","unstructured":"Fischer M, Baessler A, Schunkert H (2002) Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 53:672\u2013677","journal-title":"Cardiovasc Res"},{"key":"9573_CR11","doi-asserted-by":"crossref","first-page":"R759","DOI":"10.1152\/ajpregu.00595.2004","volume":"288","author":"SA Dean","year":"2005","unstructured":"Dean SA, Tan J, O\u2019Brien ER et\u00a0al (2005) 17Beta-estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats. Am J Physiol Regul Integr Comp Physiol 288:R759\u2013R766","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"9573_CR12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1126\/science.7839143","volume":"267","author":"SW John","year":"1995","unstructured":"John SW, Krege JH, Oliver PM et\u00a0al (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267:679\u2013681","journal-title":"Science"},{"key":"9573_CR13","doi-asserted-by":"crossref","unstructured":"Sangaralingham SJ, Tse MY, Pang SC (2004) Estrogen is involved in attenuating cardiac hypertrophy in female ANP+\/\u2212 treated with high salt. J Hypertens Suppl 22, S200. (Abstract)","DOI":"10.1097\/00004872-200402001-00856"},{"key":"9573_CR14","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/00004872-199509000-00003","volume":"13","author":"DR Rutledge","year":"1995","unstructured":"Rutledge DR, Sun Y, Ross EA (1995) Polymorphisms within the atrial natriuretic peptide gene in essential hypertension. J Hypertens 13:953\u2013955","journal-title":"J Hypertens"},{"key":"9573_CR15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1067\/mhj.2003.52","volume":"145","author":"M Gruchala","year":"2003","unstructured":"Gruchala M, Ciecwierz D, Wasag B et\u00a0al (2003) Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. Am Heart J 145:125\u2013131","journal-title":"Am Heart J"},{"key":"9573_CR16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/01.HYP.0000144801.09557.4c","volume":"44","author":"V Franco","year":"2004","unstructured":"Franco V, Chen YF, Oparil S et\u00a0al (2004) Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling. Hypertension 44:746\u2013750","journal-title":"Hypertension"},{"key":"9573_CR17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1011087513774","volume":"219","author":"MY Tse","year":"2001","unstructured":"Tse MY, Watson JD, Sarda IR et\u00a0al (2001) Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice. Mol Cell Biochem 219:99\u2013105","journal-title":"Mol Cell Biochem"},{"key":"9573_CR18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1022884515544","volume":"245","author":"SJ Sangaralingham","year":"2003","unstructured":"Sangaralingham SJ, Pak BJ, Tse MY et\u00a0al (2003) Expression of the translational repressor NAT1 in experimental models of cardiac hypertrophy. Mol Cell Biochem 245:183\u2013190","journal-title":"Mol Cell Biochem"},{"key":"9573_CR19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/01.HYP.0000215579.81408.8e","volume":"47","author":"S Klotz","year":"2006","unstructured":"Klotz S, Hay I, Zhang G et al (2006) Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction. Hypertension 47:901\u2013911","journal-title":"Hypertension"},{"key":"9573_CR20","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00004872-200018090-00018","volume":"18","author":"X Zhao","year":"2000","unstructured":"Zhao X, White R, Van Huysse J et\u00a0al (2000) Cardiac hypertrophy and cardiac renin-angiotensin system in Dahl rats on high salt intake. J Hypertens 18:1319\u20131326","journal-title":"J Hypertens"},{"key":"9573_CR21","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.mcna.2004.06.002","volume":"88","author":"JL Izzo Jr","year":"2004","unstructured":"Izzo JL Jr, Gradman AH (2004) Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure. Med Clin North Am 88:1257\u20131271","journal-title":"Med Clin North Am"},{"key":"9573_CR22","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/oxfordjournals.eurheartj.a059434","volume":"10","author":"GE Garavaglia","year":"1989","unstructured":"Garavaglia GE, Messerli FH, Schmieder RE et\u00a0al (1989) Sex differences in cardiac adaptation to essential hypertension. Eur Heart J 10:1110\u20131114","journal-title":"Eur Heart J"},{"key":"9573_CR23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1476-5381.1993.tb13871.x","volume":"110","author":"MY Farhat","year":"1993","unstructured":"Farhat MY, Chen MF, Bhatti T et\u00a0al (1993) Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats. Br J Pharmacol 110:719\u2013723","journal-title":"Br J Pharmacol"},{"key":"9573_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jcem-65-1-1","volume":"65","author":"JE Sealey","year":"1987","unstructured":"Sealey JE, Cholst I, Glorioso N et\u00a0al (1987) Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle. J Clin Endocrinol Metab 65:1\u20135","journal-title":"J Clin Endocrinol Metab"},{"key":"9573_CR25","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.CIR.94.6.1304","volume":"94","author":"RE Schmieder","year":"1996","unstructured":"Schmieder RE, Langenfeld MRW, Friedrich A et\u00a0al (1996) Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation 94:1304\u20131309","journal-title":"Circulation"},{"key":"9573_CR26","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1161\/01.HYP.19.5.456","volume":"19","author":"YF Chen","year":"1992","unstructured":"Chen YF, Naftilan AJ, Oparil S (1992) Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 19:456\u2013463","journal-title":"Hypertension"},{"key":"9573_CR27","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1097\/00004872-199312050-00092","volume":"11","author":"J Bachmann","year":"1993","unstructured":"Bachmann J, Wagner J, Haufe C et\u00a0al (1993) Modulation of blood pressure and the renin-angiotensin system in transgenic and spontaneously hypertensive rats afer ovariectomy. J Hypertens Suppl 11:S226\u2013S227","journal-title":"J Hypertens Suppl"},{"key":"9573_CR28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00004872-199204000-00007","volume":"10","author":"MS Gordon","year":"1992","unstructured":"Gordon MS, Chin WW, Shupnik MA (1992) Regulation of angiotensinogen gene expression by estrogen. J Hypertens 10:361\u2013366","journal-title":"J Hypertens"},{"key":"9573_CR29","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1161\/01.CIR.87.6.1816","volume":"87","author":"KK Griendling","year":"1993","unstructured":"Griendling KK, Murphy TJ, Alexander RW (1993) Molecular biology of the renin-angiotensin system. Circulation 87:1816\u20131828","journal-title":"Circulation"},{"key":"9573_CR30","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/hc3601.095577","volume":"104","author":"M Eickels van","year":"2001","unstructured":"van Eickels M, Grohe C, Cleutjens JP et\u00a0al (2001) 17Beta-estradiol attenuates the development of pressure-overload hypertrophy. Circulation 104:1419\u20131423","journal-title":"Circulation"},{"key":"9573_CR31","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.biocel.2005.01.012","volume":"37","author":"M Kurdi","year":"2005","unstructured":"Kurdi M, De Mello WC, Booz GW (2005) Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components. Int J Biochem Cell Biol 37:1357\u20131367","journal-title":"Int J Biochem Cell Biol"},{"key":"9573_CR32","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00004872-199715070-00003","volume":"15","author":"KB Brosnihan","year":"1997","unstructured":"Brosnihan KB, Weddle D, Anthony MS et\u00a0al (1997) Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys. J Hypertens 15:719\u2013726","journal-title":"J Hypertens"},{"key":"9573_CR33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/01.HYP.29.1.394","volume":"29","author":"P Li","year":"1997","unstructured":"Li P, Chappell MC, Ferrario CM et\u00a0al (1997) Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 29:394\u2013400","journal-title":"Hypertension"},{"key":"9573_CR34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.HYP.27.3.523","volume":"27","author":"KB Brosnihan","year":"1996","unstructured":"Brosnihan KB, Li P, Ferrario CM (1996) Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 27:523\u2013528","journal-title":"Hypertension"},{"key":"9573_CR35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.jhh.1001523","volume":"17","author":"R Antikainen","year":"2003","unstructured":"Antikainen R, Grodzicki T, Palmer AJ et\u00a0al (2003) The determinants of left ventricular hypertrophy defined by Sokolow-Lyon criteria in untreated hypertensive patients. J Hum Hypertens 17:159\u2013164","journal-title":"J Hum Hypertens"},{"key":"9573_CR36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1524-6175.2003.01246.x","volume":"5","author":"WS Post","year":"2003","unstructured":"Post WS, Hill MN, Dennison CR et\u00a0al (2003) High prevalence of target organ damage in young, African American inner-city men with hypertension. J Clin Hypertens (Greenwich) 5:24\u201330","journal-title":"J Clin Hypertens (Greenwich)"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-007-9573-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-007-9573-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-007-9573-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:11:13Z","timestamp":1559355073000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-007-9573-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,23]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,10,18]]}},"alternative-id":["9573"],"URL":"https:\/\/doi.org\/10.1007\/s11010-007-9573-8","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,23]]}}}